We are live on
!
Find out more
LPC
Lion Point Capital Portfolio holdings
AUM
$16.7M
1-Year Est. Return
119.35%
This Fund
S&P 500
This Quarter
Est. Return
+10.4%
1 Year Est. Return
+119.35%
3 Year Est. Return
+204.43%
5 Year Est. Return
+220.32%
10 Year Est. Return
+1,396.08%
AUM
$243M
AUM Growth
-$460M
(-65%)
Cap. Flow
-$470M
Cap. Flow
% of AUM
-193.58%
Top 10 Holdings %
Top 10 Hldgs %
89.97%
Holding
39
New
8
Increased
2
Reduced
9
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Semtech
SMTC
|
+$76.7M |
| 2 |
Dianthus Therapeutics
DNTH
|
+$3.15M |
| 3 |
MRSN
Mersana Therapeutics
MRSN
|
+$2.3M |
| 4 |
TSVT
2seventy bio
TSVT
|
+$1.94M |
| 5 |
Aclaris Therapeutics
ACRS
|
+$1.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WisdomTree
WT
|
+$26.5M |
| 2 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$16.1M |
| 3 |
EXE
Expand Energy Corp
EXE
|
+$16M |
| 4 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
+$10M |
| 5 |
Insmed
INSM
|
+$6.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.4% |
| 2 | Energy | 18.02% |
| 3 | Healthcare | 15.59% |
| 4 | Industrials | 7.69% |
| 5 | Consumer Discretionary | 1.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$781B
| $61.4M | 25.29% |
150,000
-907,000
| -86% | -$362M |
|
|
2
Semtech
SMTC
$12.2B
| $59.2M | 24.38% |
+2,452,855
| New | +$76.7M |
|
3
Chord Energy
CHRD
$7.86B
| $28.5M | 11.72% |
211,403
| – | – |
|
|
ARNC
4
DELISTED
Arconic Corporation
ARNC
| $18.7M | 7.69% |
712,358
-100,000
| -12% | -$2.46M |
|
|
MRNS
5
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $18.1M | 7.44% |
2,620,096
-1,602,552
| -38% | -$10M |
|
6
Ardelyx
ARDX
$1.25B
| $9.76M | 4.02% |
2,036,667
+151,667
| +8% | +$512K |
|
|
PDCE
7
DELISTED
PDC Energy, Inc.
PDCE
| $8.37M | 3.45% |
130,398
| – | – |
|
|
DRRX
8
DELISTED
DURECT Corp
DRRX
| $6.47M | 2.66% |
1,428,306
| – | – |
|
|
CIVI
9
DELISTED
Civitas Resources
CIVI
| $4.44M | 1.83% |
65,000
-50,000
| -43% | -$3.24M |
|
|
10
Dianthus Therapeutics
DNTH
$5.68B
| $3.62M | 1.49% |
+284,904
| New | +$3.15M |
|
11
Seres Therapeutics
MCRB
$49.5M
| $3.38M | 1.39% |
29,840
| – | – |
|
|
BFI
12
DELISTED
BurgerFi International, Inc. Common Stock
BFI
| $3.24M | 1.33% |
2,745,938
| – | – |
|
|
CTIC
13
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $2.53M | 1.04% |
601,579
-3,101,072
| -84% | -$16.1M |
|
14
Battalion Oil
BATL
$34.6M
| $2.5M | 1.03% |
380,891
+19,840
| +5% | +$184K |
|
15
Mirum Pharmaceuticals
MIRM
$6.86B
| $2.33M | 0.96% |
97,000
| – | – |
|
|
TSVT
16
DELISTED
2seventy bio
TSVT
| $1.73M | 0.71% |
+170,000
| New | +$1.94M |
|
|
MRSN
17
DELISTED
Mersana Therapeutics
MRSN
| $1.68M | 0.69% |
+16,365
| New | +$2.3M |
|
18
Milestone Pharmaceuticals
MIST
$146M
| $1.68M | 0.69% |
425,207
| – | – |
|
19
Kiniksa Pharmaceuticals
KNSA
$4.83B
| $1.22M | 0.5% |
113,540
-232,960
| -67% | -$3.07M |
|
|
20
Aclaris Therapeutics
ACRS
$749M
| $889K | 0.37% |
+109,898
| New | +$1.39M |
|
|
CBAY
21
DELISTED
Cymabay Therapeutics
CBAY
| $867K | 0.36% |
99,425
-120,000
| -55% | -$961K |
|
|
22
Insmed
INSM
$23.1B
| $858K | 0.35% |
50,335
-346,834
| -87% | -$6.74M |
|
|
ORGN
23
DELISTED
Origin Materials
ORGN
| $427K | 0.18% |
3,333
| – | – |
|
|
BLU
24
DELISTED
BELLUS Health Inc.
BLU
| $324K | 0.13% |
45,000
-105,000
| -70% | -$814K |
|
|
STSA
25
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $223K | 0.09% |
+319,742
| New | +$294K |
|
Similar funds
PA
PA
SR
SCTC
SRA
CP
B
CVV
Lion Point Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Lion Point Capital held 39 positions worth $243M, down 65% from $703M the previous quarter. Its ten largest holdings account for 90% of the portfolio.
Lion Point Capital withdrew a net $470M in Q1 2023, closing 8 positions and reducing 9 holdings. Its most notable exit was WisdomTree, an estimated $26.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 0.06% a quarter earlier, followed by Energy and Healthcare.
Against the trend, Lion Point Capital opened a new position in Semtech worth $59.2M.
- Lion Point Capital's largest Q1 2023 buy was Semtech: 2,452,855 shares worth $59.2M.
- Lion Point Capital added most to Ardelyx in Q1 2023, an estimated $512K increase.
- Lion Point Capital's biggest Q1 2023 reduction was CTI BioPharma Corp. (DE) Common Stock, cutting an estimated $16.1M.
- Lion Point Capital fully exited WisdomTree in Q1 2023, selling an estimated $26.5M.
- Lion Point Capital's ten largest holdings make up 90% of its $243M portfolio in Q1 2023.
- Lion Point Capital opened 8 new positions and closed 8 in Q1 2023.
- Lion Point Capital's portfolio value fell 65% quarter-over-quarter to $243M.
Based on Lion Point Capital's 13F filing for Q1 2023, filed 15 May 2023.